726
Views
7
CrossRef citations to date
0
Altmetric
Commentary

Near future of tumor immunology: Anticipating resistance mechanisms to immunotherapies, a big challenge for clinical trials

, , & ORCID Icon
Pages 1109-1111 | Received 28 Nov 2016, Accepted 02 Dec 2016, Published online: 02 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tobias Sprenger, Volker Schirrmacher, Wilfried Stücker & Stefaan W van Gool. (2020) Position paper: new insights into the immunobiology and dynamics of tumor–host interactions require adaptations of clinical studies. Expert Review of Anticancer Therapy 20:8, pages 639-646.
Read now
Chia-Lin Pan & Feng-Chi Chen. (2017) Patent trend and competitive analysis of cancer immunotherapy in the United States. Human Vaccines & Immunotherapeutics 13:11, pages 2583-2593.
Read now

Articles from other publishers (5)

Peter Van de Vliet, Tobias Sprenger, Linde F. C. Kampers, Jennifer Makalowski, Volker Schirrmacher, Wilfried Stücker & Stefaan W. Van Gool. (2023) The Application of Evidence-Based Medicine in Individualized Medicine. Biomedicines 11:7, pages 1793.
Crossref
Stefaan W. Van Gool, Peter Van de Vliet, Linde F.C. Kampers, Jennifer Kosmal, Tobias Sprenger, Ella Reich, Volker Schirrmacher & Wilfried Stuecker. 2023.
Volker Schirrmacher, Tobias Sprenger, Wilfried Stuecker & Stefaan W. Van Gool. (2020) Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit. Biomedicines 8:8, pages 237.
Crossref
Elisabetta Rossi & Rita Zamarchi. (2019) Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era?. Frontiers in Genetics 10.
Crossref
Victor Hugo Fonseca de Jesus, Tiago Cordeiro Felismino, Milton José de Barros e Silva, Virgílio de Souza e Silva & Rachel P Riechelmann. (2018) Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies. Clinics 73, pages e510s.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.